Your browser doesn't support javascript.
loading
Phase I study of pegylated interferon-alpha-2b as an adjuvant therapy in Japanese patients with malignant melanoma.
Yamazaki, Naoya; Uhara, Hisashi; Wada, Hidefumi; Matsuda, Kenji; Yamamoto, Keiko; Shimamoto, Takashi; Kiyohara, Yoshio.
Afiliação
  • Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. nyamazak@ncc.go.jp.
  • Uhara H; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Wada H; Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Matsuda K; Japan Development, MSD K.K., Tokyo, Japan.
  • Yamamoto K; Japan Development, MSD K.K., Tokyo, Japan.
  • Shimamoto T; Japan Development, MSD K.K., Tokyo, Japan.
  • Kiyohara Y; Dermatology Division, Shizuoka Cancer Center, Sunto-Gun, Japan.
J Dermatol ; 43(10): 1146-1153, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27087489
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Neoplasias Cutâneas / Adjuvantes Imunológicos / Interferon-alfa / Melanoma Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Neoplasias Cutâneas / Adjuvantes Imunológicos / Interferon-alfa / Melanoma Idioma: En Ano de publicação: 2016 Tipo de documento: Article